2020
DOI: 10.3390/cells9040892
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy

Abstract: Cancer stem cells (CSCs) are a great challenge in the fight against cancer because these self-renewing tumorigenic cell fractions are thought to be responsible for metastasis dissemination and cases of tumor recurrence. In comparison with non-stem cancer cells, CSCs are known to be more resistant to chemotherapy, radiotherapy, and immunotherapy. Elucidation of mechanisms and factors that promote the emergence and existence of CSCs and their high resistance to cytotoxic treatments would help to develop effectiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
64
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 62 publications
(65 citation statements)
references
References 269 publications
(757 reference statements)
1
64
0
Order By: Relevance
“…Packaged nanoparticles with miR-34a can downregulate the level of CD44 marker of CSCs in a mouse model of prostate cancer (Wang et al, 2016). Although the success of targeting CSCs has been limited, this may soon be a viable option for intervention strategies, disease identification, metastasis prevention, and identification of selective drug targets (Kabakov et al, 2020). Recently, many CSCs have demonstrated phenotypic plasticity and altered their transcriptomes under therapeutic challenges to escape destruction, cooperating with intratumoral heterogeneity and the immune microenvironment (Miranda et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Packaged nanoparticles with miR-34a can downregulate the level of CD44 marker of CSCs in a mouse model of prostate cancer (Wang et al, 2016). Although the success of targeting CSCs has been limited, this may soon be a viable option for intervention strategies, disease identification, metastasis prevention, and identification of selective drug targets (Kabakov et al, 2020). Recently, many CSCs have demonstrated phenotypic plasticity and altered their transcriptomes under therapeutic challenges to escape destruction, cooperating with intratumoral heterogeneity and the immune microenvironment (Miranda et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Several molecular chaperones are determinants of cancer cell stemness and potential targets for therapeutic approaches directed against CSCs [ 28 , 29 ]. They are involved in the maintenance of the CSC phenotype and are components of the cytoprotective machinery, allowing CSCs to survive to unfavorable environments.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, hypoxic niches are enriched of cancer stem cells (CSCs) that are usually chemoresistant [ 176 ], because they have higher expression of ABC transporters [ 177 , 178 ] and HIF-1α-mediated up-regulation of MMP9, C-X-C chemokine receptor type 4 (CXCR4), osteopontin, IL-8 and VEGF [ 179 ] that promote invasion and chemoresistance. In addition, CSCs may show a differential UPR response than differentiated cells [ 180 ].…”
Section: Hypoxia and Altered Upr: Two Partners In Crime Of Chemoresismentioning
confidence: 99%